MANAGEMENT OF THE HOSPITALIZED TYPE I DIABETIC PATIENT Riverside Methodist Hospital January 23, 2014 Rundsarah Tahboub, MD.

Slides:



Advertisements
Similar presentations
Role of Nursing in the Continuum of Inpatient Diabetes Care
Advertisements

Management of Inpatient Hyperglycemia in Special Populations
Inpatient Hyperglycemia Management
Advanced Pumping. Objectives: Identify situations to utilize temporary basal rate in pump therapy patients. Identify examples of when to use combination.
In-Patient Management of Hyperglycemia Rey Vivo, MD Assistant Professor of Medicine Texas Tech University Health Sciences Center.
SMH DKA PROTOCOL Physician Information. Insulin Drip protocol for DKA  Purpose: Quick/Safe management of the patient in DKA  Method: Evidence based.
Introducing The SHINE Trial (Stroke Hyperglycemia Insulin Network Effort) An Overview for Clinical Nurses NIH-NINDS U01 NSO69498.
BLOOD GLUCOSE CONTROL A learning module for Staff.

Canadian Diabetes Association Clinical Practice Guidelines In-Hospital Management of Diabetes Chapter 16 Robyn Houlden, Sara Capes, Maureen Clement, David.
HOSPITAL BASED MANAGEMENT OF DIABETES MELLITUS
Treatment of diabetes mellitus in hospitals Done by: Fatimah Al-Shehri Pharm.D Candidate King Abdulaziz university Supervised by: Dr.Hani Hassan Clinical.
Inpatient Glycemic Management Patients with Non-Critical illness Approaches and Tools.
Glycemic Control in Acutely Ill Patients Martin J. Abrahamson, MD FACP Associate Professor of Medicine, Harvard Medical School Senior Vice President for.
Putting Pump Policies Into Practice- Case Study Conference Call Elizabeth Blair, ANP-BC,CDE Joyce Lekarcyk, RN, CDE.
Management of Diabetes Mellitus in the Hospital
INPATIENT DIABETES GUIDE Ananda Nimalasuriya M.D..
Correction Insulin for Inpatient Hyperglycemia Estelle Lin June 2012.
Insulin therapy.
Perioperative Diabetes Management Dr. Ken Locke March 2007.
INSULIN THERAPY IN TYPE 1 DIABETES
Are You A Candidate For An Insulin Pump?
Management of Inpatient Blood Glucose at Temple Housestaff Orientation 2014.
The Patient Undergoing Surgery: Proven Steps to Better Outcomes Ariel U. Spencer, MD Lafayette Surgical Clinic Lafayette, Indiana.
4-06 CHANGE IS GOOD: THE BASAL BOLUS INSULIN CONCEPT Management of Hyperglycemia in the Adult Hospitalized Patient TEAM MEMBERS: Physicians: Maryann Emanuele,
Module 3 Initial Recognition, Triaging, and Management of Hyperglycemia Diabetes Special Interest Group Georgia Hospital Association.

Endocrine Disorders in the Pediatric Client Susan Beggs, MSN, CPN Susan Beggs, MSN, CPN.
L.M. Fisk, A.J. Le Compte, G.M. Shaw, S. Penning, T. Desaive, J.G. Chase Pilot Trial of STAR in Medical ICU INTRODUCTION Background: Accurate glycemic.
Basal and Meal Time Insulin Case Study
Inpatient Glycemic Management
The Basics of Insulin Pump Therapy Diabetes Care Center Patty Lord, RN,BSN, CDE Joyce Jones, RN,BSN,CDE Revised 8/2012.
1 Module 6 Review of Policies and Order Sets Diabetes Special Interest Group Georgia Hospital Association.
1 Carb Counting and Insulin Administration Module Georgia Hospital Association Diabetes Special Interest Group.
EVALUATION OF CONVENTIONAL V. INTENSIVE BLOOD GLUCOSE CONTROL Glycemic Control in Critically Ill Patients DANELLE BLUME UNIVERSITY OF GEORGIA COLLEGE OF.
Achieving Glycemic Control in the Hospital Setting Part 4 of 4.
Basal Bolus: The Strategy for Managing All Diabetes Fall, 2003 Paul Davidson, MD, FACE Atlanta Diabetes Associates Atlanta, Georgia.
K. Ann Caudell, PhD, ACNP - BC. * Identify patients with out-of-range CBGs * Assist in maintaining CBGs between 80 mg/dL & 180 mg/dL during hospitalization.
Module 41 Module 4 Pharmacologic Management of Hyperglycemia in the Hospital Part 1: Understanding How to Use Insulin Diabetes Special Interest Group Georgia.
Hypoglycemia & Hyperglycemia Dave Joffe, BSPharm, CDE, FACA Part 4.
PERI OPERATIVE DIABETES MANAGEMENT GUIDELINES AUSTRALIAN DIABETES SOCIETY.
INSULIN PUMPS Shelby Polk DNP, FNP-BC, CDE. 2 MANAGEMENT OF DIABETES IN SCHOOLS Exercise Legal Rights Health & Learning Nutrition Insulin Administration.
50% Basal Total Daily Dose Split to mimic Euglycemic control 50% Bolus Establishing Starting Basal and Bolus Dosing Based on Pre-Meal Readings and Carb.
1 Module 5 Pharmacologic Management of Hospital Hyperglycemia: Insulin Management Part 2 Diabetes Special Interest Group Georgia Hospital Association.
Safety and Efficacy of Sitagliptin Therapy for the Inpatient Management of General Medicine and Surgery Patients With Type 2 Diabetes A pilot, randomized,
Achieving Glycemic Control in the Hospital Setting (Part 2 of 4)
1 Challenges and Opportunities In Managing Diabetes and Hyperglycemia Module 2 Diabetes Special Interest Group Georgia Hospital Association.
Achieving Glycemic Control in the Hospital Setting
ADDITIONAL SLIDES FOR ASSIST WITH COMPREHENSION OF LAB CONTENT-MODULE FIVE-DM DENISE TURNER, MS-N.ED, RN, CCRN.
Spotlight Dropping to New Lows. Source and Credits This presentation is based on the April 2016 AHRQ WebM&M Spotlight Case ○ See the full article at
DIABETIC KETOACIDOSIS Emergency pediatric – PICU division H. Adam Malik Hospital – Medical School University of Sumatera Utara 1.
Insulin order sets – only way to order sustained insulin. Separate versions for 1 st time order and revision.
Special Situations In The Management Of In-Patient Hyperglycemia
Strategies to Reduce Hypoglycemia Presented by: Hennie Garza, M.S., R.Ph., C.D.E, Director of Pharmacy Utilization and Outcomes Senior Care Centers
Dallas, TX November 2–4, 2012 Effective Glycemic Control Outside of the Critical Care Unit Christopher A. Newton, MD, FACE Division of.
New Subcutaneous Insulin Protocol for Type 2 Diabetics
Inpatient Glycemic Management
Pharmacy Protocol for Insulin Dosing in the Hospitalized Patient
Management of diabetes mellitus in hospitalized patients
Emergency Care Part 3: Surgery in Children with Diabetes
Insulin Pump Continuation in the Hospital
Management of Hyperglycemia in the Noncritical Care Setting
Approach to starting and adjusting insulin in type 2 diabetes.
Managing Hypoglycemia & Hyperglycemia
A: Subcutaneous insulin therapy may be selected as continuation of ambulatory therapy, as new therapy, or as a transition plan from intravenous infusion.
Emergency Care Part 3: Surgery in Children with Diabetes
INSULINS Dr.R.Sajjad december INSULINS Dr.R.Sajjad december 2018.
Insulin Delivery Systems Atlanta Diabetes Associates
Inpatient Insulin Management on the Wards
MANDATORY INSULIN EDUCATION
Presentation transcript:

MANAGEMENT OF THE HOSPITALIZED TYPE I DIABETIC PATIENT Riverside Methodist Hospital January 23, 2014 Rundsarah Tahboub, MD

CASE  A 44 year old male is transferred from an outside hospital with low back pain and hyperglycemia after recent spinal surgery. The patient uses an insulin pump at home and it is unclear if he has Type I or II Diabetes. He was initiated on an intravenous insulin infusion at the outside facility for glucose of 300 and his pump was removed.  On admission the patient was not able to state how much insulin he gets through pump on a daily bases  The admitting hospitalist discontinued the insulin drip and began sliding scale insulin.  The patient became severely hyperglycemic shortly afterward and developed ketoacidosis  He was found to have an epidural abscess

QUESTIONS I  What is the best insulin regimen for this patient ? 1. Aggressive corrective sliding scale insulin since he has a severe infection 2. Glargine insulin and standard corrective sliding scale insulin 3. Variable intravenous insulin infusion 4. Have him put his pump back on

QUESTION II  What would you do if patient became hypoglycemic while NPO on your insulin regimen? 1. Discontinue insulin altogether 2. Reduce insulin doses 3. Correct hypoglycemia with IV dextrose 50 once 4. Initiate IV dextrose infusion

QUESTION III  All the following are appropriate criteria for reinitiating of insulin pump except one: 1. Will only resume at home after discharge 2. Hemodynamically stable and AOX3 3. Able to tolerate diet 4. Has insulin pump supplies and able to fill pump and administer boluses

HOSPITALIZED TYPE I DM PATIENT  High risk patient  Completely dependent on exogenous insulin  Insulin sensitive usually requires <0.5 units/kg/day  Frequent use of insulin pumps  Will develop ketoacidosis in absence of sufficient basal insulin:  SSI monotherapy  Holding basal insulin when NPO  Delay in responding to stress hyperglycemia DKA occurring after admission in a hospitalized patient is a result of medical error until proven otherwise

COMMON ERRORS IN MANAGEMENT OF INPATIENT TYPE I DM  Holding basal insulin for NPO status or hypoglycemia severe hyperglycemia or DKA  Omitting mealtime insulin for low premeal BG (60-80 )  Using SSI only  Assuming Type I patient is as insulin resistant as Type II patients when correcting hyperglycemia

RECOMMENDED GLYCEMIC TARGETS  Targets Must be: Achievable Reasonable Safe Critically IllNon critically Ill mg/dL Premeal <140 mg/dL Random <180 mg/dL NOT recommended BG <110 mg/dL Consider changing regimen for BG <100 mg/dL

NON CRITICALLY ILL TYPE I DM  Continue to require an insulin regimen similar to home regimen but modified for being inpatient with potential less PO intake  Regimen consists of:  Basal insulin  long acting glargine or detemir  intermediate acting NPH  Mealtime insulin (analog) must be scheduled if patient is eating  Corrective insulin for premeal glucose above target of 150 typically

NON CRITICALLY ILL TYPE I DM & NPO STATUS  Must always continue exogenous basal insulin  Long or intermediate acting insulin  Basal rate of insulin pump if suitable  Initiation of IV insulin especially in critical care setting  May use corrective insulin in addition to basal

PERIOPERATIVE MANAGEMENT OF TYPE I DM  Basal insulin should always be continued  Using glargine or detemir  If well controlled give 80% of dose  Uncontrolled may give the full dose  Using NPH  Give full evening dose  Give 50% of AM dose  Avoid use of mixed insulin 70/30, 75/25  Hold scheduled mealtime insulin but may continue to use corrective doses  If undergoing high risk surgery such as CABG or prolonged procedures initiate IV insulin infusion the night before

Insulin Pump Therapy Electronic device that delivers insulin through a SC catheter Can be programmed to deliver variable basal rates throughout the day Delivers bolus /mealtime coverage based on carbohydrate intake with meals : insulin to carbohydrate ratio programmed into pump. Example 1 unit per 15 gm of carb per meal correction factor : example 1 unit of insulin drops BG by 50mg/dl

CHALLENGES OF INSULIN PUMP THERAPY IN HOSPITAL SETTING  Patient may be unfamiliar with the pump settings but know how to use pump otherwise ( fill with insulin, insert SC catheter, bolus for meals and give correction doses )  Hospital Staff usually unfamiliar with pumps  Safety issues with pumps (kinked catheter, overbolused, discontinued by staff without alternate insulin orders)  Technical concerns (safety with radiological testing, intraopertively)

REQUIREMENTS FOR SAFE INPATIENT USE OF INSULIN PUMP THERAPY  Insulin pump order set  Patient contract  Nursing documentation of basal rates and boluses administered by patient & evaluation of insertion site  Pharmacy overview of pump & patients insulin supply  Endocrine consult

INPATIENT INSULIN PUMP THERAPY  Criteria for maintaining pump  The patient is alert and oriented  Not critically ill  Able to administer boluses and suspend pump when needed  Cooperation with staff and signs patient contract  Patient has own supplies

INSULIN PUMP THERAPY IN PERIOPERTAIVE PERIOD  May continue use of pump for short procedures <2 hours and insulin insertion site away from surgical site  Reduce basal rate by 20% of usual  For procedures >2 hours  Initiate IV insulin infusion the night before at same rate as the insulin pump infusion rate  Discontinue insulin pump

CRITICALLY ILL TYPE I DM & NPO STATUS  IV insulin infusion is the method of choice until condition is stabilized  Often need D5 IVF initiated also if  expected to be NPO for prolonged periods  BGs trending <150  IV insulin infusion rates may be titrated down as low as 0.1 units/hour to avoid hypoglycemia while still providing IV insulin without interruption

CRITICALLY ILL TYPE I DM & NPO STATUS  If enteral nutrition is going to be initiated IV insulin infusion is the safest and most flexible method of achieving control  IV insulin should be maintained until the patient is tolerating enteral nutrition and at goal rate

WHEN IS PATIENT READY TO BE TRANSITIONED FROM IV TO SC INSULIN?  Hemodynamically stable  DKA or HHS resolved  Insulin infusion rate has been stable for 6-8 hours  Insulin infusion rate < 5 units/hour  Insulin infusion rates are similar to patient prior insulin requirements  Medications that effect BG have not been recently changed  Inotropes  Glucocorticoids

CONSIDERATIONS WHEN TRANSITIONING FROM IV TO SQ INSULIN  Continue IV insulin until patient is able to tolerate PO intake (diabetic clear liquids) if not on EN or PN  Continue IV insulin at least 2 h after the first SC basal insulin injection is given or pump is started (Overlap is essential)  Is patient receiving Dextrose in IVF or have they eaten on Insulin Infusion?  Do not use the total insulin IV amount given in previous 24 hours  Don’t switch to SSI only !

FEEDING WHILE ON INSULIN INFUSION  The insulin infusion will not prevent hyperglycemia associated with ingestion of carbohydrates  Insulin infusion is reactive  Interferes with our ability to calculate insulin requirements when transitioning off of infusion  If you are going to feed on insulin give a SC dose of short acting insulin before the meal  Giving a IV bolus is not going to cover the meal..its effect only lasts 5- 10mins

HOW TO TRANSITION FROM IV TO SQ INSULIN  Type I DM on IV insulin and D5 IVF (such as DKA)  Use stable insulin infusion rate in past 6 hours to calculate total daily dose (TDD)  Example:  Stable average infusion rate 2 units/hour  2 units/hour x 24 hours =48 units (TDD)

HOW TO TRANSITION FROM IV TO SQ INSULIN  Type I DM on IV insulin and D5 IVF (DKA)  Divide the new TDD as follows:  50% Basal ( to be given 2-3 hours before discontinuation of insulin IV)  50% as premeal divided into 3 doses  Example : TDD 48 units calculated from IV insulin  24 units glargine  24/3 units as premeal analog insulin = Lispro 8 units with each meal

HOW TO TRANSITION FROM IV TO SQ INSULIN  Type I on TPN or continuous tube feeds  Use stable insulin infusion rate in past 6 hours to calculate TDD  Divide the new TDD as follows:  50% Basal either glargine every 24 hours or equal dose of NPH q 12 hours  50% as nutritional given as regular insulin scheduled Q 6 hours

HOW TO TRANSITION FROM IV TO SQ INSULIN  Type I on TPN or continuous tube feeds  Example average hourly rate over previous 6 hours while on goal tube feeds = 3.5 units/hour  3.5 x 24 hours = 84 units  Give 50% as basal = 42 units of glargine  even if TF discontinued this dose should be continued  Give 50% as nutritional = 42 units ÷ 4 ~ 10 units q 6 hours while on TF  this is to be held if TF interrupted  Also start correctional SSI

HOW TO TRANSITION FROM IV TO SQ INSULIN  Type I DM (Not receiving dextrose, TPN or Tube feed)  Use stable insulin infusion rate in past 6 hours to calculate total basal dose  Example:  infusion rate 2 units/hour  2 x 24 hours =48 units  Give 80% as the Total basal dose for next 24 hours  0.8 x 48=40 units  Give all of this as basal insulin  Give premeal insulin roughly unit/kg with each meal when patient starts eating

TRANSITIONING FROM IV TO INSULIN PUMP  Insulin pump should be placed and started at least 1-2 hours before IV infusion is discontinued

QUESTIONS ??

REFERENCES  Umpierrez GE, Hellman R, Korytkowski MT, et al. Management of hyperglycemia in hospitalized patients in non-critical care setting: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2012;97:  American Diabetes Association. Standards of medical care in diabetes— Diabetes Care. 2013;36(suppl 1):S11-S66.  Moghissi ES, Korytkowski MT, DiNardo M, et al. American Association of Clinical Endocrinologists and American Diabetes Association consensus statement on inpatient glycemic control. Endocr Pract. 2009;15: